Chandler Villaverde1,2, Ruth Namazzi3, Estela Shabani4,5, Gregory S Park4, Dibyadyuti Datta5, Benjamin Hanisch6, Robert O Opoka3, Chandy C John4,5. 1. Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. 2. Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. 3. Department of Paediatrics and Child Health, Makerere University College of Health Sciences, Kampala, Uganda. 4. Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota, USA. 5. Department of Pediatrics, Indiana University, Indianapolis, Indiana, USA. 6. Department of Pediatrics, Children's National Medical Center, Washington, District of Columbia, USA.
Abstract
BACKGROUND: Our prior study findings suggest that Plasmodium falciparum is the cause of disease in both malaria retinopathy-positive (RP) and most retinopathy-negative (RN) cerebral malaria (CM), and that absence of retinopathy and decreased disease severity in RN CM may be due to shorter duration of illness, lower parasite biomass, and decreased var gene expression in RN compared to RP CM. In the present study, we assessed the pathophysiology of RP and RN CM. METHODS: We compared markers of systemic and central nervous system inflammation, oxidative stress, neuronal injury, systemic endothelial activation, angiogenesis, and platelet activation in Ugandan children with RP (n = 167) or RN (n = 87) CM. RESULTS: RP children had higher plasma C-reactive protein (P = .013), ferritin and erythropoietin (both P < .001) levels, an elevated cerebrospinal fluid (CSF):plasma albumin ratio (P < .001), and higher CSF tau protein levels (P = .049) than RN children. Levels of plasma and CSF proinflammatory and anti-inflammatory cytokines and oxidative stress markers did not differ between RP and RN children. RN children had higher plasma levels of endothelin 1 (P = .003), platelet-derived growth factor (P = .012), and platelet factor 4 (P = .034). CONCLUSIONS: RP and RN CM may represent different phases of CM. RN CM may be driven by early vasospasm and platelet activation, whereas the more advanced RP CM is associated with greater inflammation, increased erythropoietic drive, blood-brain barrier breakdown, and neuronal injury, each of which may contribute to greater disease severity.
BACKGROUND: Our prior study findings suggest that Plasmodium falciparum is the cause of disease in both malaria retinopathy-positive (RP) and most retinopathy-negative (RN) cerebral malaria (CM), and that absence of retinopathy and decreased disease severity in RN CM may be due to shorter duration of illness, lower parasite biomass, and decreased var gene expression in RN compared to RP CM. In the present study, we assessed the pathophysiology of RP and RN CM. METHODS: We compared markers of systemic and central nervous system inflammation, oxidative stress, neuronal injury, systemic endothelial activation, angiogenesis, and platelet activation in Ugandan children with RP (n = 167) or RN (n = 87) CM. RESULTS: RP children had higher plasma C-reactive protein (P = .013), ferritin and erythropoietin (both P < .001) levels, an elevated cerebrospinal fluid (CSF):plasma albumin ratio (P < .001), and higher CSF tau protein levels (P = .049) than RN children. Levels of plasma and CSF proinflammatory and anti-inflammatory cytokines and oxidative stress markers did not differ between RP and RN children. RN children had higher plasma levels of endothelin 1 (P = .003), platelet-derived growth factor (P = .012), and platelet factor 4 (P = .034). CONCLUSIONS: RP and RN CM may represent different phases of CM. RN CM may be driven by early vasospasm and platelet activation, whereas the more advanced RP CM is associated with greater inflammation, increased erythropoietic drive, blood-brain barrier breakdown, and neuronal injury, each of which may contribute to greater disease severity.
Authors: Irene Gramaglia; Joyce Velez; Valery Combes; Georges E R Grau; Melanie Wree; Henri C van der Heyde Journal: Blood Date: 2017-01-17 Impact factor: 22.113
Authors: Andrea L Conroy; Simon J Glover; Michael Hawkes; Laura K Erdman; Karl B Seydel; Terrie E Taylor; Malcolm E Molyneux; Kevin C Kain Journal: Crit Care Med Date: 2012-03 Impact factor: 7.598
Authors: Yuri C Martins; Brandi D Freeman; Oscar B Akide Ndunge; Louis M Weiss; Herbert B Tanowitz; Mahalia S Desruisseaux Journal: Am J Pathol Date: 2016-09-15 Impact factor: 4.307
Authors: D G Lalloo; A J Trevett; M Paul; A Korinhona; I F Laurenson; J Mapao; N Nwokolo; B Danga-Christian; J Black; A Saweri; S Naraqi; D A Warrell Journal: Am J Trop Med Hyg Date: 1996-08 Impact factor: 2.345
Authors: Nicholas A Beare; Caroline Southern; Chipo Chalira; Terrie E Taylor; Malcolm E Molyneux; Simon P Harding Journal: Arch Ophthalmol Date: 2004-08
Authors: Terrie E Taylor; Wenjiang J Fu; Richard A Carr; Richard O Whitten; Jeffrey S Mueller; Nedson G Fosiko; Susan Lewallen; N George Liomba; Malcolm E Molyneux; Jeffrey G Mueller Journal: Nat Med Date: 2004-01-25 Impact factor: 53.440
Authors: Happy T Phiri; Daniel J Bridges; Simon J Glover; Jan A van Mourik; Bas de Laat; Bridon M'baya; Terrie E Taylor; Karl B Seydel; Malcolm E Molyneux; E Brian Faragher; Alister G Craig; James E G Bunn Journal: PLoS One Date: 2011-11-17 Impact factor: 3.240
Authors: Laurent Rénia; Shanshan Wu Howland; Carla Claser; Anne Charlotte Gruner; Rossarin Suwanarusk; Teck Hui Teo; Bruce Russell; Lisa F P Ng Journal: Virulence Date: 2012-03-01 Impact factor: 5.882
Authors: Catherine Manix Feintuch; Alex Saidi; Karl Seydel; Grace Chen; Adam Goldman-Yassen; Neida K Mita-Mendoza; Ryung S Kim; Paul S Frenette; Terrie Taylor; Johanna P Daily Journal: MBio Date: 2016-02-16 Impact factor: 7.867
Authors: Mary Tetteh; Otchere Addai-Mensah; Zakaria Siedu; Eric Kyei-Baafour; Helena Lamptey; Jovis Williams; Edward Kupeh; Godfred Egbi; Anna Boadi Kwayie; Gabriel Abbam; David Amoah Afrifah; Alexander Yaw Debrah; Michael Fokuo Ofori Journal: J Inflamm Res Date: 2021-04-14
Authors: Steven T DeKosky; Patrick M Kochanek; Alex B Valadka; Robert S B Clark; Sherry H-Y Chou; Alicia K Au; Christopher Horvat; Ruchira M Jha; Rebekah Mannix; Stephen R Wisniewski; Max Wintermark; Susan E Rowell; Robert D Welch; Lawrence Lewis; Stacey House; Rudolph E Tanzi; Darci R Smith; Amy Y Vittor; Nancy D Denslow; Michael D Davis; Olena Y Glushakova; Ronald L Hayes Journal: J Neurotrauma Date: 2020-11-11 Impact factor: 5.269